Brainlab, a digital medical technology company, presented Loop-X, the first mobile intraoperative imaging robot, at the Arab Health 2020 in Dubai from 27-30 January
Loop-X is at the heart of the Brainlab Digital Surgery portfolio for the rapidly evolving spinal market. Brainlab is leveraging its long history of 3D imaging and open integration to bring to market a new benchmark in automation and robotics that helps surgeons provide advanced care while improving surgery for patients.
The Loop-X robotic architecture introduces a new standard in flexibility, adding additional degrees of freedom to any surgical procedure: By automating imaging workflow steps and robotically moving with the procedure and on command, the system is in sync with other devices like robotic arms and with the surgeon and staff. The non-isocentric movement and collimation capabilities allow for the imaging of structures that are much larger—for example in diameter—and much smaller—reducing radiation exposure—than what is possible with the typical CT or 3D C-arm.
The device is designed for 2D and 3D imaging, combining ultra-high resolution with extra-low doses, and proprietary technology to image with interlaced energies for soft-tissue visualisation. Loop-X imaging robot can be integrated with Brainlab technology as well as third party products through an open interface, maximising interoperability and data integration.
“For Brainlab, Loop-X is a critical milestone in contributing disruptive innovations in spinal surgery,” said Stefan Vilsmeier, president and CEO, Brainlab.
“It provides us with an even stronger foundation for leveraging emerging technologies such as AI, big data, cloud computing, augmented reality and spatial computing.”
Loop-X imaging robot has been developed by medPhoton in close partnership with Brainlab. Brainlab has co-funded development, strategically invested in the Salzburg-based company, and become the exclusive distributor of Loop-X imaging robot in surgery, underscoring the company’s commitment to innovation. Both companies are fully dedicated to maximising technological synergies for the ultimate benefit of surgeons and their patients and have agreed upon a path forward toward further deepening the collaboration and integrating their activities in the future.
